Naureen Quibria

Stock Analyst at Capital One

(n/a)
# 4,648
Out of 5,043 analysts
8
Total ratings
11.11%
Success rate
-44.7%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Naureen Quibria

Biomea Fusion
Aug 29, 2024
Initiates: Overweight
Price Target: $25
Current: $1.46
Upside: +1,612.33%
Immutep
May 17, 2024
Initiates: Overweight
Price Target: $10
Current: $2.04
Upside: +390.20%
Erasca
Mar 11, 2024
Initiates: Overweight
Price Target: $8
Current: $2.38
Upside: +236.13%
Immunocore Holdings
Aug 16, 2023
Initiates: Overweight
Price Target: $84
Current: $33.18
Upside: +153.16%
Day One Biopharmaceuticals
Feb 8, 2023
Initiates: Overweight
Price Target: $40
Current: $7.49
Upside: +434.05%
Fennec Pharmaceuticals
Sep 7, 2022
Initiates: Overweight
Price Target: $11
Current: $8.99
Upside: +22.36%
Genenta Science
Jan 13, 2022
Initiates: Buy
Price Target: $21
Current: $6.20
Upside: +238.71%
Kazia Therapeutics
Oct 14, 2021
Initiates: Buy
Price Target: $900
Current: $7.05
Upside: +12,665.96%